MedTrace Logo

Effect of Weight Reduction on Immunity

NCT03336086 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2017-11-08

No results posted yet for this study

Summary

This study included two groups of premenopausal healthy obese women. Experimental group underwent a weight loss program involved a low calorie diet plus anti-obesity drugs and moderate physical activity and control group underwent an ad libitum diet. At baseline and after a 10-15% weight loss lymphocyte subgroups were analyzed and compared between two group.

Conditions

  • Lymphocytes
  • Weight Loss
  • Viral Diseases
  • Immunity
  • Anti-obesity Agents

Interventions

COMBINATION_PRODUCT

weight loss program

A low calorie diet+ Orlistat+ Soluble Fiber+ Physical activity

Sponsors & Collaborators

  • Mashhad University of Medical Sciences

    collaborator OTHER

  • Shiraz University of Medical Sciences

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-20
Primary Completion
2012-11-30
Completion
2012-12-25
FDA Drug
Yes
FDA Device
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03336086 on ClinicalTrials.gov